Upacicalcet

N/A

Report date: 2022/05/08 14:33:04
NME

Base Information

Drug NameUpacicalcet
Drug Alias NameUpacicalcet sodium hydrateUPASITAUpasitaウパシタSK-1403 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor agonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsHyperparathyroidism, Secondary
Global Approved IndicationsHyperparathyroidism, Secondary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2021/06/23
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanwa Kagaku Kenkyusho Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperparathyroidism, Secondary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG